Position in PRQR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$494,527
-$1,116,753 QoQ
Shares Held
305,264
-61.7% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRQR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. PRQR ranks #289 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in PRQR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $494,527 | 305,264 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,611,280 | 797,664 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $201,391 | 94,550 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,333,422 | 1,143,835 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,376,774 | 1,787,049 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,121,631 | 2,310,050 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,278 | 2,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,726 | 27,546 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,381 | 4,970 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,722 | 3,900 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $13,057 | 10,044 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $7,583 | 4,681 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,668 | 3,600 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,892 | 2,944 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $3,792 | 5,098 | Shares | Sole | 2022-11-10 | |
| 2021-12-31 | $675,459 | 84,327 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $787,750 | 94,116 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $417,967 | 62,013 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $598,965 | 90,615 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,982,832 | 472,103 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,291,176 | 478,325 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,932,177 | 482,266 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $2,649,523 | 482,609 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||